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The major regulatory factors in the mesenteric circulation include general hemodynamic forces, the
autonomic nervous system, circulating vasoactive substances, tissue metabolites and intrinsic characteristics
of vascular smooth muscle. During mesenteric ischemic states smooth muscle spasm elevates resistance to
blood flow and aggravates intestinal tissue hypoxia leading to mucosal necrosis. Close intraarterial infusion
of potent vasodilator drugs holds the promise of reversing intestinal ischemia and preserving viability of the
gut.
The splanchnic circulation which courses through the liver is one of the largest
vascular regions of the body. The two largest branches of the aorta pass to the
splanchnic viscera. This circulation is doubly complex because of its unusual mor-
phologic organization and because ofthe variety oforgans to which it delivers blood.
Despite these challenging features the splanchnic circulation has attracted few inves-
tigators, which is unfortunate from a medical viewpoint. Each year hundreds of
thousands of Americans die from primary diseases of the splanchnic vessels, most
notably ischemia and hemorrhage.
CONTROL OF SPLANCHNIC BLOOD FLOW
One of the first questions one asks about a regional circulation is this: what
regulates its blood flow? Factors influencing splanchnic blood flow include general
hemodyamic factors, the autonomic nervous system, circulating neurohumoral
agents, local metabolites and certain properties of splanchnic blood vessels [1,2].
General hemodynamic factors include cardiac output, systemic arterial blood
pressure, blood volume and the like. Any major decline in these factors, as would
occur in hemorrhagic shock, would be reflected by a decline in visceral blood flow.
Both divisions ofthe autonomic nervous system affect gastrointestinal blood flow.
Sympathetic nervous stimuli constrict arteriolar smooth muscle in splanchnicviscera,
thereby raising resistance to blood flow through these organs. Sympathetic ischemia
seems to be a transient response, however, in the hepatic and mesenteric portions of
the splanchnic circulation. Parasympathetic stimulation evokes vasodilation secon-
dary to the increased metabolic activity observed with secretory and motor responses
to cholinergic input.
Circulating neurohumoral agents appear not to be of major consequence as
physiological regulators ofblood flow to gastrointestinal viscera. However, in severe
stress states such as hemorrhagic shock, many vasoconstrictive agents are released
into the blood. These include catecholamines from the adrenal medulla, angiotensin
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All rights of reproduction in any form reserved.II from the kidneys andvasopressin from the posterior pituitary. These agents reduce
blood flow to the viscera.
Closer to the blood vessels themselves are the parenchymal cells of the splanchnic
organs-hepatocytes, enterocytes, secretory cells ofthe gastric mucosa and pancreas,
visceral muscle and endocrine cells, and the many other cell types which metabolize
actively in this region. As cells metabolize they change the chemical environment in
which nearby blood vessels exist by lowering the partial pressure of oxygen, increa-
sing C02 and producing de novo metabolites: nucleotides, such as cyclic AMP and
ATP; polypeptides, like bradykinin; amines, e.g., histamine; and fatty acid deriva-
tives, i.e., prostaglandins. Cells also can alter the composition of electrolytes around
the blood vessels by increasing interstitial potassium and magnesium concentrations.
These metabolic changes relax arteriolar smooth muscle, reduce vascular resistance
and increase blood flow to the cells to support metabolic activity.
Certain properties ofsome splanchnic vessels play a role in controlling blood flow.
One ofthese properties is termed "autoregulation" and is best seen in the mesenteric
circulation. Autoregulation may be defined as the intrinsic ability of a regional
circulation to maintain a steady blood flow in the face of fluctuating arterial blood
pressure. Thus, forexample,duringhemorrhagic shock in which arterial hypotension
occurs, blood flow is maintained near normal levels for some time in organs which
exhibit autoregulation-the brain, heart, kidneys and small intestine.
"Escape" is another property of the hepatic and mesenteric vasculature. Escape
occurs during continuous sympathetic nervous stimulation or infusion of catecho-
lamines [3]. Initially blood flow to the gut declines but then recovers in a matter of
minutes to control values despite continuous constrictor input from sympathetic
nerves ornorepinephrine. The survival value ofautoregulation and escape should be
apparent, since organs require a steady flow of blood to sustain metabolically
dependent functions.
Less favorable features also occur in the splanchnic vasculature. Without altering
total blood flow to a hollow organ of thedigestive tract, sympathetic stimulation can
redistribute the flow by decreasing mucosal perfusion and increasing blood flow to
the muscularis of the wall. This is an adverse characteristic of the system during
ischemic states because the mucosa ismetabolically more active than the muscle layer
and is more vulnerable to the destructive effects of a compromised blood supply.
The oxygen counter current exchanger is another feature of the mesenteric micro-
circulation which must be viewed as a mixed blessing [2]. Coursing down the core of
each intestinal mucosal villus is an inflow arteriole and an outflow venule. These
vessels carry blood to and from the capillaries of the tip of the villus. The arteriole
and venule are 10-20 micra apart; these vessels run counter current to one another
and have different concentrations ofphysically dissolved oxygen in their blood. Since
oxygen is lipid soluble, this gas can diffuse out of arteriolar blood across the lipid
membranes ofthe intervening vessels and entervenous blood draining away from the
villus. The result is a lower partial pressure of oxygen at the tip of the villus than is
found at the base which may contribute to the rapid turnover cycle of surface
epithelial cells which die and are sloughed at the tip of the villus. During ischemic
states the flow of blood is slowed through villus vessels, thereby increasing the
opportunity for counter-current exchange of oxygen from inflow to outflow vessels.
This shunting of oxygen away from capillaries at the tip of the villus further
compounds the hypoxia of the region and is responsible for the observation of the
pathologist that tissue necrosis invariably commences at the tip ofthe villus in severe
intestinal ischemic states.
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PATHOPHYSIOLOGY OF MESENTERIC ISCHEMIA
AND DILATOR THERAPY
The events which transpire during fatal intestinal ischemia are depicted in Fig. 1
[4]. The typical patient is elderly, is suffering from congestive cardiac failure and is
being treated with cardiac glycosides. The patient sustains an acute abdominal crisis
characterized by severe pain and is taken to a hospital. Often the patient is found to
be in a state ofcirculatory shock upon admission. The systemic arterial hypotension
of shock prompts release of circulating constrictor agents-catecholamines, angio-
tensin II and vasopressin-and activates sympathetic nervous discharge. The fall in
arterial pressure also induces collapse of microcirculatory vessels as their critical
closing pressure is reached. The diminshed cardiac output in shock leads to a slowing
of blood flow throughout the body with microthrombi forming, especially in venules.
As the velocity of flowing blood slows, its viscosity rises. Protracted shock states lead
to acidosis. Sympathetic activity redistributes blood flow away from the mucosa into
the muscularis of the gut. Mucosal ischemia leads to hypoxia of the tissue which is
aggravated by acidosis and by the oxygen counter-current exchanger mechanism of
the villus. Necrosis ensues beginning at the tip ofthe villi. The necrotic mucosa fails
to contain toxic materials in its lumen and there is absorption into the dying
circulation of such materials as bacterial endotoxins, cellular debris, lysosomal
hydrolases and cathepsins, and electrolytes. Superimposition of a profound toxemia
upon intestinal ischemia and shock in an elderly patient in heart failure is intolerable.
Reported mortality rates for severe intestinal ischemia hover around 100%.
Recently Siegelman et al. reported some success in the use ofintraarterial vasodila-
tor therapy in intestinal ischemic states [5]. The agent they chose was papaverine.
Since many dilator drugs are known, it is of more than academic interest to consider
the minimal but essential criteria for an effective drug to counteract intestinal
ischemic disease. The agent should be a potent vasodilator which relaxes both
arteriolar smooth muscle and precapillary smooth muscle. The arterioles are the
major resistance vessels of the mesenteric circulation and their relaxation will result
in augmented blood flow to the gut. The precapillary sphincters control perfusion
through the vessels across which the exchange of oxygen from blood to cells must
take place. Relaxation of these sphincters increases availability of oxygen and
increases oxygen uptake.
Another essential property ofan effective vasodilator drug is that ofselectivity. It is
requisite that normal blood flow be reestablished in ischemic gut by relaxation ofthis
constricted circulation. However, if the drug relaxes smooth muscle in all peripheral
circulations, it will become impossible for the heart to maintain a normal driving
head of pressure to propel the blood to the tissues including the intestine. Thus, the
drug must not induce a fall in systemic arterial pressure when it is dilating the
mesenteric circulation. To avoid this untoward effect the drugcan be infused directly
into the mesenteric artery via an intraarterial catheter in minute amounts. Since the
drug must be infused for a long period to break up the vasospasm and sustain blood
flow at levels compatible with survival of the gut, there is danger of accumulating
sufficient quantities of the drug in the general circulation to depress systemic arterial
blood pressure. To avoid the depressor effect and limit the vasodilator action to the
mesenteric circulation during intraarterial infusion, an effective drug would be one
which is rapidly degraded by the tissues of the gut, blood, liver and lung into an
inactive metabolite.









FIG. 1. A diagram of the sequence of pathophysiological events occurring in fatal nonocclusive intestinal ischemia.
ence with various steps in the pathophysiological responses of intestinal tissue to the
ravages of ischemia. During prolonged ischemic disease the gut is subjected to
damage by lysosomal hydrolases and cathepsins. Stasis of blood in the intestinal
vasculature predisposes to the development of microthrombi which further impede
the flow of blood through the tissue. An effective drug should stabilize lysosomal
membranes and oppose formation of microthrombi.
In order to compare the efficacy of various candidate agents which might be
effective in treating mesenteric ischemia, it is necessary to use experimental models.
The intestinal circulation ofananimal can provide the initial testingground onwhich
favorable or adverse characteristics of dilator drugs may be discovered. The finding
of a significant pharmacological property in the canine mesenteric vasculature does
not mean that this feature will necessarily appearwith use ofthe drug in the intestinal
vessels ofsubhuman primates or in the patient. Thisconsideration does not, however,
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justify neglect of suitable experimental testing of agents before their new use in
desperately sick patients simply because the drug is available and there is little to lqse.
At the present time it is fairly easy to estimate effect ofintraarterially infused drugs
on mesenteric blood flow, systemic arterial and portal venous pressures, and the
arteriovenous oxygen gradient in experimental animals.
Intestinal blood flow can be measured in the laporatomized and anesthetized
animal without violating the integrity of the arterial vessel. Implantation of a cuff-
type electromagnetic blood flow transducer and occlusive zeroing device permit the
continuous measurement of superior mesenteric artery blood flow. Via catheters
connected to strain gauge transducers, systemic arterial and portal venous pressures
can be determined. Siphoning of a small portion of systemic arterial and portal
venous blood flow into the cuvettes of a spectrophotometric arteriovenous oxygen
analyzer allows measurement of the transintestinal oxygen gradient. From such
measurements one can calculate mesenteric vascular resistance and intestinal oxygen
consumption [6].
Using a canine preparation in which the preceding measurements and calculations
were obtained during continuous intraarterial infusion of papaverine, we found that
this drug exhibited an adverse property. Despite an ability to provoke large increases
in blood flow to the gut, papaverine caused a decrease in intestinal oxygen consump-
tion in the normotensive animal. When the dogs were shocked with gram negative
endotoxin, thereby producing profound ischemia and greatly reduced oxygen uptake
by the gut, infusion ofpapaverine into the mesenteric artery further lowered oxygen
uptake by the hypoxic intestine [7].
By contrast, intraarterial infusion of prostaglandin El induced not only a pro-
nounced increase in mesenteric blood flow and a nearly equal increase in intestinal
oxygen consumption in either normotensive or shocked dogs [6,8,9]. The dose of
prostaglandin E1 needed to elicit such responses was 0.1 ug/kg-min. Because of its
rapid metabolism to inactive forms by 15 prostaglandin dehydrogenase in the gut
wall, liver and lung, intraarterial infusion ofprostaglandin Ei was not associated with
any systemic arterial depressor effect. Prostaglandin El has also been shown to
stabilize lysosomal membranes and to antagonize platelet aggregation. Recently we
have employed prostaglandin Ei as a pharmacoangiographic aid in visualizing
mesenteric and portal vessels in dogs [10] and in patients undergoing diagnostic
angiography. A single dose of 7.5 ug injected into the superior mesenteric artery 15
seconds before injection of the contrast medium greatly enhanced visualization of
both arterial and venous phases of the angiogram in our clinical trials of the drug.
Given the many dilator drugs which are available, it would appear that further
comparative studies are warranted. Such investigations should utilize sub human
primate models where feasible. The ability ofthe interventional radiologist to insert a
catheter into any sizable vessel offers the opportunity to deliver potent and selective
agents to manipulate blood flow in desired directions in order to reverse the course of
life-threatening vascular diseases.
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